Ocular RNA Nanomedicine: Engineered Delivery Nanoplatforms in Treating Eye Diseases

Yiming Zhang,Yesi Shi,Muhammad M. Khan,Fan Xiao,Wei Chen,Wei Tao,Ke Yao,Na Kong
DOI: https://doi.org/10.1016/j.tibtech.2024.05.002
2024-01-01
Trends in Biotechnology
Abstract:Ocular disorders remain a major global health challenge with unmet medical needs. RNA nanomedicine has shown significant therapeutic benefits and safety profiles in patients with complex eye disorders, already benefiting numerous patients with gene-related eye disorders. The effective delivery of RNA to the unique structure of the eye is challenging owing to RNA instability, off-target effects, and ocular physiological barriers. Specifically tailored RNA medication, coupled with sophisticated engineered delivery platforms, is crucial to guide and advance developments in treatments for oculopathy. Herein we review recent advances in RNA-based nanomedicine, innovative delivery strategies, and current clinical progress and present challenges in ocular disease therapy.
What problem does this paper attempt to address?